Neurocrine Biosciences, Inc.

ISIN US64125C1099

 | 

WKN 900964

Market cap (in EUR)
13,172 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 13,172 m
EPS, EUR 3.79
P/B ratio 5.1
P/E ratio 36.8
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 2,177 m
Net income, EUR 316 m
Profit margin 14.49%

What ETF is Neurocrine Biosciences, Inc. in?

There are 35 ETFs which contain Neurocrine Biosciences, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Neurocrine Biosciences, Inc. is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares MSCI World UCITS ETF (Dist) 0.02%
Equity
World
7,468
UBS Core MSCI World UCITS ETF USD acc 0.01%
Equity
World
4,695
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) 0.05%
Equity
World
Health Care
Social/Environmental
438
JPMorgan Global Equity Premium Income Active UCITS ETF USD (acc) 0.22%
Equity
World
Covered Call
Alternative Investments
71
iShares MSCI USA Islamic UCITS ETF 0.11%
Equity
United States
Islamic Investing
255
JPMorgan Active US Growth UCITS ETF EUR Hedged (acc) 0.33%
Equity
United States
Growth
9
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.24%
Equity
United States
Small Cap
176
iShares MSCI USA ESG Enhanced CTB UCITS ETF USD (Dist) 0.01%
Equity
United States
Social/Environmental
13,478
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing 0.01%
Equity
World
Multi-Factor Strategy
139
iShares MSCI North America UCITS ETF 0.02%
Equity
North America
1,105
iShares MSCI World Islamic UCITS ETF 0.07%
Equity
World
Islamic Investing
768
UBS Core MSCI World UCITS ETF USD dis 0.01%
Equity
World
1,204
iShares MSCI World Screened UCITS ETF USD (Dist) 0.02%
Equity
World
Social/Environmental
819
iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist) 0.01%
Equity
World
Social/Environmental
Climate Change
131
JPMorgan Global Research Enhanced Index Equity (ESG) UCITS ETF USD (dist) 0.07%
Equity
World
Social/Environmental
1,659
JPMorgan All Country Research Enhanced Index Equity Active UCITS ETF USD (dist) 0.06%
Equity
World
Social/Environmental
52
UBS Core MSCI World UCITS ETF hGBP dis 0.01%
Equity
World
91
UBS Core MSCI USA UCITS ETF USD dis 0.02%
Equity
United States
1,192
JPMorgan Active US Growth UCITS ETF USD (acc) 0.33%
Equity
United States
Growth
359
Amundi Core MSCI World UCITS ETF USD Dist 0.02%
Equity
World
820
iShares MSCI ACWI UCITS ETF USD (Acc) 0.01%
Equity
World
20,831
Amundi MSCI North America ESG Broad Transition UCITS ETF Dist 0.01%
Equity
North America
Social/Environmental
Climate Change
26
JPMorgan Global Equity Premium Income Active UCITS ETF USD (dist) 0.22%
Equity
World
Covered Call
Alternative Investments
1,107
iShares MSCI USA Screened UCITS ETF USD (Dist) 0.02%
Equity
United States
Social/Environmental
1,336
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
483
Amundi Core MSCI USA UCITS ETF Dist 0.02%
Equity
United States
-
UBS Core MSCI World UCITS ETF hEUR acc 0.01%
Equity
World
274
UBS Core MSCI USA UCITS ETF EUR Hedged dis 0.02%
Equity
United States
326
iShares MSCI World ESG Enhanced CTB UCITS ETF USD (Dist) 0.01%
Equity
World
Social/Environmental
937
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.18%
Equity
United States
Health Care
Biotech
44
JPMorgan US Research Enhanced Index Equity (ESG) UCITS ETF USD (dist) 0.07%
Equity
United States
Social/Environmental
935
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating 0.01%
Equity
World
Multi-Factor Strategy
755
JPMorgan Active US Growth UCITS ETF USD (dist) 0.33%
Equity
United States
Growth
1
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.02%
Equity
North America
Social/Environmental
27
JPMorgan US Equity Premium Income Active UCITS ETF USD (dist) 0.01%
Equity
United States
Covered Call
Alternative Investments
214
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.